Clindalaf

Active principle: Clindamycin.
Therapeutic Effect: Hard capsules and injectable solution: Reduced-spectrum antibiotic. Vaginal cream, vaginal suppositories and topical dermal solution: Antimicrobial.
Composition: Hard capsules: Each capsule contains: Clindamycin (as hydrochloride) 300 mg. Solution for injection 900 mg: Each 6 ml ampoule contains: Clindamycin (as Clindamycin phosphate) 900 mg. Solution for injection 600 mg: Each 4 ml ampoule contains: Clindamycin (as Clindamycin phosphate) 600 mg. Dermal topical solution: Every 100 g of solution: Clindamycin phosphate 1.188 g (equivalent to 1 g of Clindamycin base). Vaginal cream: Each 100 g contains: Clindamycin phosphate 2.376 g (equivalent to 2 g of Clindamycin base). Vaginal suppositories: Each suppository contains: Clindamycin (as phosphate) 100 mg.
How Supplied: Hard capsules: Packages containing 8, 10, 16, 32, 100 (EH), 500 (EH) and 1000 (EH) capsules. Injectable solution: Containers containing 1, 2, 3, 5, 10 (EH), 50 (EH), 100 (EH), 500 (EH) and 1000 (EH) ampoules. Vaginal cream: Containers containing 1 tube per 40 g with 7 applicators. Vaginal suppositories: Containers containing 1, 3, 5, 7, 14, 50 (EH), 100 (EH), 500 (EH), and 1000 (EH) suppositories. Topical solution: Bottles containing 5 ml, 10 ml, 15 ml, 20 ml and 40 ml.